Intellectual Property and Emerging Technologies
Show Less

Intellectual Property and Emerging Technologies The New Biology

The New Biology

  • Queen Mary Studies in Intellectual Property series

Edited by Matthew Rimmer and Alison McLennan

This unique and comprehensive collection investigates the challenges posed to intellectual property by recent paradigm shifts in biology. It explores the legal ramifications of emerging technologies, such as genomics, synthetic biology, stem cell research, nanotechnology, and biodiscovery.
Buy Book in Print
Show Summary Details
You do not have access to this content

Chapter 4: Patent Law, the Emerging Biotechnologies and the Role of Language in Subject-Matter Expansionism

Graham Dutfield

Extract

JOBNAME: Rimmer PAGE: 1 SESS: 2 OUTPUT: Thu Dec 22 13:16:36 2011 4. Patent law, the emerging biotechnologies and the role of language in subject-matter expansionism Graham Dutfield This short chapter is about science, patent law and the use of language that supports the extension of patent claims ever deeper into the realms of nature. By language I refer in particular to the use of figures of speech, terminologies and epistemologies that both express and support powerful explanatory and justificatory conceptual systems. Undoubtedly, chemical, informational and mechanistic ways of understanding life have all been enormously helpful to scientists, as are the metaphors and analogies that frame their verbal and written forms of expression. The point of the chapter is not to undermine them but to examine critically what implications they have for patent law and policy, in particular their consequences for the positioning of boundaries between the patentable and the unpatentable. From the mid nineteenth century, patents were regularly being granted on chemical substances in those countries, like the United States, the United Kingdom and France, that had no statutory chemical exclusions.1 In the early twentieth century, patents claiming isolated and purified natural compounds were allowed or else found by courts to constitute acceptable subject matter. Since the 1970s an increasing number of jurisdictions have granted patents on micro-organisms, cell cultures, seeds, plants, animals and genes. Patenting in the life sciences is often criticised for inappropriate expansionism. I would argue that some but not all...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.


Further information

or login to access all content.